Skip to main content
SpringerLink
Log in

Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas

A phase II study of the Northern California Oncology Group

  • Brief Report
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kamen BA, Eibl B, Cashmore AR, Bertino JR: Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-(3,4,5-trimethoxyanilino) methyl] quinazoline), a nonclassical antifolate in methotrexate-resistant leukemia cells in vitro. Biochem Pharmacol 33:1697–1699, 1984

    Google Scholar 

  2. Jackson RC, Leopold WR, Hamelehle KL, Fry DW: Preclinical studies with trimetrexate: A review of conclusions and unanswered questions. Semin Oncol 15 (2 Suppl 2):1–7, 1988

    Google Scholar 

  3. Lathan B, Von Hoff DD, Elslager E: Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone. Cancer Treat Rep 68:733–738, 1984

    Google Scholar 

  4. Steward JA, McCormack JJ, Tong W, DeLap RJ, Grillo-Lopez AJ: A phase I study of trimetrexate. (Abstract) Proc Am Assoc Cancer Res 26:159, 1985

    Google Scholar 

  5. Rosen M, Ohnuma T, Zimet A, Coffey V, Zhang N, Holland JF: Phase I study of trimetrexate (trimetrexate, TMQ, JB-11) glucuronate in a 5 day infusion schedule. (Abstract) Proc Am Assoc Cancer Res 27:172, 1986

    Google Scholar 

  6. Stewart JA: Safety and tolerance of trimetrexate: Results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists. Semin Oncol 15 (2 Suppl 2):10–16, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Stanford University, 94305, Stanford, CA, USA

    Robert W. Carlson

  2. Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 91010, Duarte, CA, USA

    James H. Doroshow & Oluwole O. Odujinrin

  3. San Joaquin Valley Community Clinical Oncology Program, 93715, Fresno, CA, USA

    Marshall S. Flam

  4. Northern California Cancer Center, 94002, Belmont, CA, USA

    Robert W. Carlson, Mary Malec & Kathleen R. Lamborn

Authors
  1. Robert W. Carlson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James H. Doroshow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Oluwole O. Odujinrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marshall S. Flam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mary Malec
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kathleen R. Lamborn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, R.W., Doroshow, J.H., Odujinrin, O.O. et al. Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. Invest New Drugs 8, 387–389 (1990). https://doi.org/10.1007/BF00198597

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198597

Key words

Search

Navigation